Stock Events

Stock Events

Aclaris Therapeutics (8AT.F) Q1 2025 Earnings

27FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.97

-0.65

-0.33

-0.01

Details

Expected EPS

-0.2756589872

Actual EPS

-0.971216

Surprise EPS

-0.7

Surprise Percent

+252.33%

Description

Aclaris Therapeutics (8AT.F) has reported earnings of -0.971216 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.